Company news
Apotex Health Corp. (TSX:APTX) news
Apotex Health Corp. news releases on 6ix. Latest, Oct 5, 2026: APOTEX HEALTH CORP. ANNOUNCES CLOSING OF $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING
Press releases & updates
APOTEX HEALTH CORP. ANNOUNCES CLOSING OF $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING
October 5, 2026
APOTEX HEALTH CORP. ANNOUNCES $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING
September 28, 2026
Apotex Announces First Quarter 2027 Results
August 12, 2026
Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement
July 16, 2026
Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026
July 9, 2026
Apotex expands U.S. hospital portfolio with launch of generic Infuvite® Adult and Pediatric Injection
July 8, 2026
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
July 1, 2026
Apotex first to receive Health Canada approval for SEVMIA(TM), a generic semaglutide for chronic weight management
June 30, 2026
APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED INITIAL PUBLIC OFFERING AND EXERCISE OF OVER-ALLOTMENT OPTION IN FULL
June 16, 2026
Apotex Health Corp. (APTX) Opens the Market
June 11, 2026
Toronto Stock Exchange Welcomes Apotex
June 10, 2026
APOTEX HEALTH CORP. FILES FINAL PROSPECTUS AND ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING
June 8, 2026